Pharmacokinetics of Chiglitazar in Subjects With Renal Impairment and Normal Renal Function
Clinical trial NCT05515458 · COMPLETED
Trial details
- NCT number
- NCT05515458
- Sponsor
- Chipscreen Biosciences, Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-20
- Primary completion
- 2023-07-19
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.